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Biliary atresia (BA) is a neonatal cholestatic jaundice which results 
from obstruction of the extrahepatic biliary system due to destructive 
inflammation of unknown aetiology. It occurs in 1/5 - 1/8 000 
live births in Asia and 1/18 - 1/20 000 children in Europe.1,2 Apart 
from this difference in incidence, no ethnic differences have been 
demonstrated. However, females appear to carry a slightly higher 
BA risk. BA affects variable lengths of the extrahepatic system 
and, if untreated, most patients die of biliary cirrhosis before 
their second birthday due to liver failure. Recognised subtypes 
include an embryonic form (BA splenic malformation (BASM)) 
associated with other congenital anomalies, as well as at least 3 other 
subtypes (isolated BA, a cystic variety, and cytomegalovirus (CMV)-
IgM-positive BA). If treated timeously by surgical drainage (Kasai 
procedure), approximately 40 - 55% of affected children can clear 
their jaundice to normal values and expect at least a 5-year native 
liver survival.2 BA is the leading cause of end-stage liver disease in 
children, leading to significant mortality and morbidity;3 therefore, 
research into potential causes would improve results, and possibly 
prevention.
The aetiology of BA is unknown, but it is generally agreed to 
be attributed to multifactorial prenatal and perinatal insults to the 
developing biliary tree. Research points towards a viral-initiating 
factor in predisposed individuals, which initiates an antigen-antibody 
reaction that causes inflammatory targeting of the extrahepatic (and 
possibly intrahepatic) bile ducts.4 This mechanism is of particular 
interest in patients with impaired immunity (e.g. HIV-infected).
CMV is related to biliary disease in infants, being cholestatic in its 
own right,5 and has been  implicated in intrahepatic bile destruction 
and duct paucity, as a potential causative factor.6,7 Patients with IgM-
CMV-positivity appear to suffer progressive liver damage, suggesting 
that the virus may promote ongoing sclerosis in the biliary tree, 
consequently affecting outcome.8 
We aimed: (i) to detect CMV infection rates and baseline 
characteristics of infants with BA over 10 years (2001 - 2011); and 
(ii) to investigate the effect of perinatal CMV infection in BA and 
compare the outcomes of CMV-IgM-positive children with non-
exposed children with cholestatic jaundice. 
Methods
We performed a retrospective review of hospital records of patients with 
cholestatic jaundice, referred to the Paediatric Surgical Unit of Tygerberg 
Hospital from 2001 to 2011 (Table 1). Data were anonymously collated 
and stored in a Microsoft Excel database. Patients were categorised 
into 2 groups: those with and those without BA (non-BA), and were 
compared in terms of CMV infection. CMV testing results were 
derived from laboratory results or patient records. Fisher’s exact and/ or 
chi-squared statistical tests for significance were performed where 
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Background. Human cytomegalovirus (CMV) infection is related 
to biliary disease, being cholestatic in its own right. It has also been 
associated with intrahepatic bile duct destruction and duct paucity, 
indicating a possible role in the pathogenesis and progression 
of extrahepatic biliary atresia (BA). BA patients who are CMV-
IgM-positive appear to have greater liver damage than uninfected 
patients, consequently affecting outcome.
Methods. We reviewed the medical records of 74 patients 
diagnosed with hepatobiliary disease between 2000 and 2011, 
assessing clinical outcome and potential risk factors. Patients, 
categorised into those with and those without BA, were compared 
in terms of CMV infection.
Results. The 74 patients included 39 (52%) BA and 35 non-BA 
patients; following the exclusion of patients due to insufficient data, 
27 (69%) BA and 31 non-BA patients were reviewed. Twenty-one 
(78%) BA patients were CMV-positive (IgM/IgG), including 20 
IgM-positive patients versus 8 in the non-BA group (p<0.01). Two 
(7.5%) CMV-IgM-positive BA infants were HIV-exposed versus 7 
(35%) in the non-BA group (p<0.01). Long-term outcomes included 
3 deaths in the non-HIV CMV-positive group and a higher rate of 
severe early liver damage, suggesting a poorer outcome in CMV-
affected patients. 
Conclusions. Our results suggest a correlation between CMV 
exposure/infection and BA which affects clinical outcome. HIV-
positivity does not preclude BA and should be investigated further.
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Table 1. Causes of cholestatic jaundice in a cohort of 74 patients
Cause N
Biliary atresia 39 (27 evaluable) 
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applicable. A p-value <0.05 was regarded as statistically significant. 
Ethical approval of the study was granted (S12/02/061) by the ethics 
review committee of Stellenbosch University. Research was conducted 
according to guidelines outlined in the Declaration of Helsinki. Patient 
anonymity and confidentiality were protected.
Results
Of the 74 patients investigated, 39 (52%) had BA and 35 had other 
causes of surgical hepatobiliary disease (Table 1); 27 (69%) BA 
patients and 31 (89%) non-BA patients were reviewed following the 
exclusion of 12 BA patients and 4 non-BA patients due to lack of 
sufficient data. Twenty-one (78%) BA patients had CMV positivity 
(IgM/IgG) on testing; 20 were IgM-positive, whereas 8 non-BA 
cholestatic jaundiced patients were IgM-positive (p<0.01). Two 
(7.5%) of 27 BA infants were HIV-exposed (born to HIV-positive 
mothers), whereas 7 (35%) of the non-BA group were HIV-positive 
(p<0.01). Both HIV-exposed BA infants were CMV-IgM-positive. 
Long-term outcomes of the 21 CMV-positive BA patients (non-HIV 
exposed) included 3 deaths and a higher rate of severe early liver 
damage, suggesting a poorer outcome in CMV-affected patients.
Discussion 
The surgical causes of prolonged neonatal jaundice include BA, hypoplasia 
of bile ducts, inspissated bile ducts, choledochal cysts and spontaneous 
bile duct perforation. BA remains the most common neonatal cholestatic 
disorder and is characterised histologically by complete obliteration of 
the lumen of all, or part, of the extrahepatic biliary tree.
Although the cause of BA is unknown and many theories as 
to its aetiology exist, it is generally agreed that it is attributed to 
multifactorial pre- and postnatal insults to the developing biliary 
tree.1,7,9,10,11 Current aetiology theories include viral infections, 
including human CMV; immune dysregulation; auto-immune 
mechanisms; vascular lesions; defective morphogenesis (including 
inherited mutations of laterality genes, somatic mutations, and 
modifier genes); and toxin exposure.4 A study showing a seasonal 
clustering of children presenting with BA supports an infective 
aetiological factor.12 Although multiple factors are involved in the 
targeting of the developing biliary tree, the correlation between viral 
infections and BA suggests the possibility that the viral infection 
initiates an inflammatory auto-immune process which results in the 
ductal sclerosis seen in the condition.13 Current information suggests 
that this is based on antibody-mediated inflammation (probably 
virally induced) which leads to progressive biliary sclerosis.4
Histological observations in the porta hepatis and liver samples of 
children with BA provide further support of a possible link between 
BA and a viral infection.14 Viruses currently identified as potential 
aetiological agents include CMV, reovirus, and herpes simplex virus, 
among others.15 Although there appears to be a correlation between 
CMV infection and BA, the significance must still be determined due 
to the small cohorts studied thus far.4,5,7,9-11,16,17
Human CMV infection is a strong candidate, being cholestatic 
in its own right.5,9 It has also been associated with intrahepatic bile 
duct destruction and ductal paucity, indicating a possible role in the 
pathogenesis and progression of extrahepatic BA.7,8 In addition, when 
related to BA, CMV-IgM-positive patients appear to have greater liver 
damage, consequently affecting outcome deleteriously.8,10,18
Although no unequivocal link has been established between BA 
and CMV infection, there appears to be a fairly strong correlation 
between the two, as demonstrated by our study. CMV is a slow 
replicating virus from the herpes family, infecting only as many as 
1% of all neonates in developed countries,9 but demonstrating up 
to 90% IgG-positivity in developing countries.19 Only 5 - 10% of 
infected infants have typical CMV inclusion disease with symptoms 
of hepatosplenomegaly, jaundice and petechiae; a further 5% having 
subclinical disease. Consequently, the vast majority of exposed 
babies are asymptomatic. The South African population has a high 
background CMV infection rate in pregnant women (M Anderson, 
personal communication); in this context, it is therefore difficult 
to determine when CMV infection is the unequivocal cause of BA. 
Nevertheless, there appears to be a connection to BA in countries 
with low CMV community prevalence.2
A principal difficulty in making the connection between these 
entities is that no single test is 100% sensitive and/or specific 
for CMV infection.1,9,13,16 Serology, CMV quantitative polymerase 
chain reaction (qPCR), immunohistochemistry and histology have 
been unable to confirm a possible role of CMV in BA aetiology. 
De Tomasso et al.9 describe a low accuracy of serological tests for 
detecting active CMV infection, with no correlation between the 
CMV-positive qPCR and histopathological changes reported by 
others.1,13,16 Our study, however, reinforces a probable correlation. 
Some information suggests a worse outcome in CMV-affected 
patients.8 Hill et al.14 have shown a connection to CMV Th1 and Th17 
cell infiltrates which affects BA prognosis. This raises the possibility 
that CMV infection might not only be a causative factor, but may 
promote ongoing biliary tree sclerosis.10,18 
The presence of co-morbidities such as HIV raises interesting 
possibilities in the antigen-antibody hypothesis of BA aetiology. 
This is of particular interest in areas of high HIV prevalence, such as 
sub-Saharan Africa, and is probably explained by the fact that some 
non-BA patients with neonatal hepatitis on biopsy were subsequently 
shown to be HIV-related. Our results, however, demonstrate that 
HIV exposure did not preclude the occurrence of BA in at least 2 
cases. Recent evidence indicates that an interaction between HIV 
infection and other environmental factors such as CMV co-infection 
accelerates immune system deterioration.20 On the other hand, 
should an antigen-antibody be important in the aetiology of BA, 
impaired immunity, such as HIV, may influence BA type and/or 
outcome. As such, this connection warrants further study.
Conclusion
Our results suggest a correlation between CMV exposure, infection 
and surgical hepatobiliary disease, including an effect on BA outcome. 
HIV positivity does not preclude BA; a relationship that requires 
further investigation.
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